Alkermes (ALKS) shares, currently trading at $31.68, are projected by Wall Street analysts to have a mean price target of $43.18, indicating a potential upside of 36.3%. While analyst price targets are generally viewed with skepticism due to potential optimism, the stock's outlook is bolstered by a strong positive trend in earnings estimate revisions, with the Zacks Consensus Estimate increasing 8.4% over the past 30 days. This strong agreement among analysts on improved earnings prospects, alongside a Zacks Rank #1 (Strong Buy), suggests a legitimate potential for near-term stock appreciation for ALKS.
Alkermes (ALKS) shares have recently seen a modest 1% gain, closing at $31.68. Wall Street analysts project a mean price target of $43.18, suggesting a substantial 36.3% potential upside, though estimates vary significantly with a standard deviation of $6.54 across 17 targets, ranging from a low of $30.00 to a high of $56.00. While the article notes general skepticism regarding analyst price targets due to potential biases, ALKS presents a more compelling case through its earnings estimate revisions. There is strong agreement among analysts on improved earnings prospects, with three estimates moving higher and no negative revisions over the past 30 days. This positive trend has led to an 8.4% increase in the Zacks Consensus Estimate for the current year. Empirical research supports a strong correlation between positive earnings estimate revisions and near-term stock price movements, further bolstered by ALKS's Zacks Rank #1 (Strong Buy) status, indicating it is among the top 5% of ranked stocks for potential upside.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
